AbbVie Inc. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AbbVie Inc. stock issued during period, value, acquisitions for the quarter ending 2020-12-31 was $0.00.
- AbbVie Inc. stock issued during period, value, acquisitions for the quarter ending 2020-09-30 was $0.00.
- AbbVie Inc. stock issued during period, value, acquisitions for the quarter ending 2020-06-30 was $24.41B.
- AbbVie Inc. stock issued during period, value, acquisitions for fiscal 2020 was $24.41B.
- AbbVie Inc. stock issued during period, value, acquisitions for fiscal 2016 was $3.92B, a 53.33% decline from fiscal 2015.
- AbbVie Inc. stock issued during period, value, acquisitions for fiscal 2015 was $8.40B.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $24.41B 10-K · filed 2023-02-17 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | |
| 2020-06-30 | $24.41B 10-Q · filed 2021-08-02 | |
| 2016-12-31 | $3.92B 10-K · filed 2019-02-27 | |
| 2015-12-31 | $8.40B 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |